脑膜炎球菌监测澳大利亚:报告期为2025年1月1日至3月31日
Monica M Lahra1,2, Tiffany R Hogan1,
1The World Health Organization Collaborating Centre for STI and AMR and Neisseria Reference Laboratory, NSW Health Pathology, Microbiology, Prince of Wales Hospital, Randwick, NSW 2031, Australia.
Communicable diseases intelligence (2018)
|July 30, 2025
概括
现在季度报告详细介绍了侵入性脑膜炎球菌病 (IMD) 病例数和血清组. 扩展到2024年的数据包括关键抗生素的抗菌素耐药性,有助于公共卫生监测.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 微生物学 微生物学
背景情况:
- 侵入性脑膜炎球菌病 (IMD) 仍然是一个重大的公共卫生问题.
- 监测数据对于了解疾病流行病学和指导干预至关重要.
研究的目的:
- 为了提高IMD数据的报告.
- 将抗菌素耐药性 (AMR) 信息纳入常规监测.
主要方法:
- 使用季度报告来追踪按司法管辖区和血清组的IMD病例数量.
- 在2024年扩大数据收集,包括特定抗生素的AMR概况.
主要成果:
- 现在季度报告提供了管辖区和特定于血清组的IMD病例数量.
- 现在可以获得对二,青素,西普罗夫洛克萨和利芬素的抗菌耐药性数据.
- 活动性脑膜炎球菌监测计划 (AMSP) 的年度报告提供了对实验室确认的全面分析.
结论:
- 增强的报告提供了更详细的IMD流行病学的图片.
- 包括抗菌耐药性数据支持明智的治疗指南和公共卫生战略.
- 持续监测对于监测和控制IMD至关重要.
更多相关视频
09:11Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
Published on: September 25, 2014
22.0K
09:31Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
Published on: April 15, 2017
18.4K
相关概念视频
01:26Principles of Disease Surveillance
182
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
182
01:19Pharmacovigilance
996
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
996